Meningioma

Overview


Plain-Language Overview

Meningioma is a type of tumor that grows from the protective layers covering the brain and spinal cord, called the meninges. It primarily affects the central nervous system by pressing on nearby brain tissue or nerves. These tumors are usually slow-growing and often benign, meaning they are not cancerous. Symptoms can vary widely depending on the tumor's size and location, including headaches, vision changes, or weakness. Diagnosis often involves imaging tests like MRI scans to visualize the tumor. Treatment options depend on symptoms and tumor characteristics but may include surgery or radiation. Understanding this condition helps explain how abnormal growths in the brain's protective layers can impact overall brain function.

Clinical Definition

Meningioma is a typically benign, slow-growing neoplasm arising from the arachnoid cap cells of the meninges, the membranous layers surrounding the brain and spinal cord. It represents the most common primary intracranial tumor in adults and is often linked to chromosomal abnormalities such as loss of chromosome 22q, which includes the NF2 gene. These tumors can cause neurological symptoms by exerting mass effect on adjacent brain structures or cranial nerves. Histologically, meningiomas are characterized by whorled cell patterns and psammoma bodies. Although most are benign (WHO grade I), atypical (grade II) and anaplastic (grade III) variants exist with more aggressive behavior. The clinical significance lies in their potential to cause focal neurological deficits, seizures, or increased intracranial pressure depending on size and location.

Inciting Event

Locked content.

Latency Period

Locked content.

Diagnostic Delay

Locked content.

Clinical Presentation


Signs & Symptoms

Locked content.

History of Present Illness

Locked content.

Past Medical History

Locked content.

Family History

Locked content.

Physical Exam Findings

Locked content.

Diagnostic Workup


Diagnostic Criteria

Locked content.

Pathophysiology


Key Mechanisms

Locked content.

Organs

Locked content.

Tissues

Locked content.

Cells

Locked content.

Chemical Mediators

Locked content.

Treatments


Pharmacological Treatments

Locked content.

Non-pharmacological Treatments

Locked content.

Prevention


Pharmacological Prevention

Locked content.

Non-pharmacological Prevention

Locked content.

Outcome & Complications


Complications

Locked content.

Short-term Sequelae

Locked content.

Long-term Sequelae

Locked content.

Differential Diagnoses


Differentials

Locked content.

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site's content were generated or assisted by AI. All material has been reviewed by Erik Romano, MD, however, errors or omissions may still occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. “USMLE Step 1” and “USMLE Step 2 CK” are used only to identify the relevant examinations.